Zynerba Pharmaceuticals Inc. (ZYNE) fell -6.1% or -0.25 to $3.85. It is close to 98361 shares traded, which is 38.06% compare to the average total volume 258413. The market cap of ZYNE is $67.86 million. The year to date change is -74.55%. The 52 week price range is from $3.86 to $14.45. Price of ZYNE have changed -12.02% during last week. It have changed -18.81% over last month, -38.35% over last 3 months, -63.43% over last 6 months and -65.78% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 5.76. It is 49.61% above current price. The 200-day Moving Averages for ZYNE is 8.19. It is 112.73% above current price. The 52-week High is 14.45. It is 275.32% from the current price. The 52-week Low is 3.86.
There are some statistics of ZYNE. It is has market cap $67.86 million. The share outstanding is 17.63 million. The average volume is 258413. The percent of top 15 Institution holding is 27.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -62.66%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -55.12%.